Medicare Enrolled
Dr. Shiraz Yussaf, M.D
Family Medicine · Hoboken, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yussaf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yussaf?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yussaf
Dr. Shiraz Yussaf is a family medicine specialist in Hoboken, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Yussaf performed 1,026 Medicare services across 694 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yussaf received a total of $7,551 from 47 pharmaceutical and/or device companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yussaf is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 29% volume in NJ
$7,551 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,026
Medicare services
Top 29% in NJ for family medicine
694
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
532 | $52 | $240 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
76 | $55 | $395 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
60 | $147 | $445 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
57 | $34 | $70 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
51 | $69 | $90 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
42 | $45 | $177 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
41 | $10 | $60 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $102 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $50 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $68 | $160 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
20 | $64 | $230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
19 | $11 | $70 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
19 | $47 | $580 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
13 | $8 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,551
Total received (2018-2024)
Avg $1,079/year across 7 years
Top 7% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,510 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,245
2023
$1,122
2022
$1,088
2021
$699
2020
$863
2019
$1,357
2018
$1,179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$244
Novo Nordisk Inc
$192
Amgen Inc.
$158
Novartis Pharmaceuticals Corporation
$141
GlaxoSmithKline, LLC.
$69
Gilead Sciences, Inc.
$66
Medtronic, Inc.
$66
PFIZER INC.
$66
Exact Sciences Corporation
$59
Astellas Pharma US Inc
$47
Abbott Laboratories
$38
Lilly USA, LLC
$19
Otsuka America Pharmaceutical, Inc.
$18
Mylan Specialty L.P.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
ABBVIE INC.
$14
Top 3 companies account for 47.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,129
AstraZeneca Pharmaceuticals LP
$974
Amgen Inc.
$737
GlaxoSmithKline, LLC.
$653
PFIZER INC.
$343
Gilead Sciences, Inc.
$320
Novartis Pharmaceuticals Corporation
$303
Merck Sharp & Dohme Corporation
$283
Lilly USA, LLC
$272
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
SANOFI-AVENTIS U.S. LLC
$235
Janssen Pharmaceuticals, Inc
$230
Abbott Laboratories
$192
Medtronic, Inc.
$176
Bayer HealthCare Pharmaceuticals Inc.
$166
Mylan Specialty L.P.
$110
Bayer Healthcare Pharmaceuticals Inc.
$105
Amarin Pharma Inc.
$97
Exact Sciences Corporation
$93
Kowa Pharmaceuticals America, Inc.
$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
VIVUS, Inc.
$59
Astellas Pharma US Inc
$59
Otsuka America Pharmaceutical, Inc.
$51
Arbor Pharmaceuticals, Inc.
$50
Allergan Inc.
$42
Horizon Therapeutics plc
$42
ARBOR PHARMACEUTICALS, INC.
$38
Allergan, Inc.
$37
Dexcom, Inc.
$33
Azurity Pharmaceuticals, Inc.
$31
AbbVie Inc.
$30
Sun Pharmaceutical Industries Inc.
$29
ABBVIE INC.
$28
Avanir Pharmaceuticals, Inc.
$27
Purdue Pharma L.P.
$27
MannKind Corporation
$26
Mannkind Corporation
$26
Biohaven Pharmaceutical Holding Company Ltd.
$17
VIVUS LLC
$16
Lexicon Pharmaceuticals, Inc.
$16
AbbVie, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Sanofi Pasteur Inc.
$14
Eisai Inc.
$12
Daiichi Sankyo Inc.
$11
GE Healthcare
$11
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · Cologuard Collection Kit · Creon · DRIZALMA SPRINKLE · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Horizant · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · NURTEC ODT · Nuedexta · Otezla · Ozempic · PANCREAZE · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 20 · QULIPTA · Qsymia · RAYOS · REXULTI · RIOMET · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tresiba · UBRELVY · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · Welchol · XARELTO · XIFAXAN · XIFIXAN · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in NJ.
Geographic Context
Family medicine physicians within 10 mi
3,220
Per 100K population
453.2
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-HOBOKEN UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yussaf is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NJ), with low-engagement industry engagement in the top 7% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yussaf experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yussaf performed 532 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yussaf receive payments from pharmaceutical companies?
Yes. Dr. Yussaf received a total of $7,551 from 47 companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yussaf's costs compare to other family medicine physicians in Hoboken?
Dr. Yussaf's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yussaf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Hoboken
Browse family medicine physicians in Hoboken ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NJ
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NJ
Which NJ family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology